Biomarin Pharmaceutical Inc (BMRN)

Financial leverage ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total assets	US$ in thousands	6,841,600	6,375,070	6,004,770	5,848,020	4,690,040
Total stockholders’ equity	US$ in thousands	4,951,550	4,603,160	4,265,670	4,100,930	3,122,380
Financial leverage ratio		1.38	1.38	1.41	1.43	1.50

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $6,841,600K ÷ $4,951,550K
= 1.38

The financial leverage ratio of Biomarin Pharmaceutical Inc has remained relatively stable over the past five years, ranging from 1.38 to 1.50. This ratio indicates that the company's financial leverage has been consistent, with a trend towards slightly decreasing leverage in recent years. A financial leverage ratio above 1 suggests that the company relies more on debt financing than equity financing to support its operations and growth. Biomarin Pharmaceutical Inc's moderate to high financial leverage may indicate a higher level of financial risk, as the company has a greater amount of debt in relation to its equity. Overall, the company's financial leverage ratio reflects a balance between debt and equity financing strategies in its capital structure.